Over-the-counter (OTC) derivatives regulation; margin requirements reporting via Umoja platform
Implementation of regulatory reporting requirements for margin on non-centrally cleared OTC derivatives, using the Umoja platform to submit returns

No data available for the deliverable: Implementation of regulatory reporting requirements for margin on non-centrally cleared OTC derivatives, using the Umoja platform to submit returns

No data available for the deliverable: Implementation of regulatory reporting requirements for margin on non-centrally cleared OTC derivatives, using the Umoja platform to submit returns

No data available for the deliverable: Implementation of regulatory reporting requirements for margin on non-centrally cleared OTC derivatives, using the Umoja platform to submit returns

No data available for the deliverable: Implementation of regulatory reporting requirements for margin on non-centrally cleared OTC derivatives, using the Umoja platform to submit returns

No data available for the deliverable: Implementation of regulatory reporting requirements for margin on non-centrally cleared OTC derivatives, using the Umoja platform to submit returns

Summary

The Umoja platform enables automated, integrated regulatory reporting for margin requirements, replacing interim systems and supporting compliance with G20/BCBS standards.

Canvas not supported.

Is it working?

The reform is effective, with improved data quality and regulatory oversight, and a smooth transition from legacy systems. The platform supports systemic risk monitoring and could expand as initial margin models come into scope.

Actions

The Umoja platform is live, institutions are engaging, and full compliance was expected by April 2025.

Are there plans?

Prudential Communication 8 of 2024 and Joint Notice 2 of 2024 detail reporting requirements, with industry training and support.

Is it on the agenda?

The SARB, Prudential Authority and FSCA have made this a key regulatory priority, with phased rollout from July 2024.

Goals

To modernise and standardise margin reporting for non-centrally cleared OTC derivatives, supporting systemic risk oversight, transparency, risk monitoring and compliance with global (G20/BCBS) standards.

Summary

The Umoja platform enables automated, integrated regulatory reporting for margin requirements, replacing interim systems and supporting compliance with G20/BCBS standards. SARB and the Prudential Authority enhance regulatory requirements for margin and collateral on non-centrally cleared OTC derivatives. Industry switched to the Umoja platform for reporting from April 2025, with alignment to international standards via trade repositories​. Initial margin phase-in has begun with new reporting for margin on qualifying derivative trades mandated.

Canvas not supported.

Is it working?

The reform is effective, with improved data quality and regulatory oversight, and a smooth transition from legacy systems. The platform supports systemic risk monitoring and could expand as initial margin models come into scope. Most industry participants are compliant and technical improvements are continuing in late 2025.

Actions

The Umoja platform is live, institutions are engaging, and full compliance was expected by April 2025. Rollout is proceeding as planned; key market participants are meeting new margin and reporting standards and some industry feedback is being used to refine protocols.

Are there plans?

Prudential Communication 8 of 2024 and Joint Notice 2 of 2024 detail reporting requirements, with industry training and support. SARB and the PA plan biannual compliance audits and will publish reporting protocols, and coordinate with Strate and industry for phased implementation.

Is it on the agenda?

The SARB, Prudential Authority and FSCA have made this a key regulatory priority, with phased rollout from July 2024. Regulators have this on targeted review as part of SARB/PA strategy, featured in SARB circulars and quarterly market risk meetings.

Goals

To modernise and standardise margin reporting for non-centrally cleared OTC derivatives, supporting systemic risk oversight, transparency, risk monitoring and compliance with global (G20/BCBS) standards.

Summary

SARB and the Prudential Authority have strengthened the regulatory framework for non‑centrally cleared OTC derivatives by phasing in initial and variation margin requirements and mandating reporting of margin and collateral data through the Umoja platform. This aligns South Africa with international post‑crisis standards and supports more effective monitoring of counterparty credit and liquidity risks. Budget Review 2026 notes continued implementation of OTC‑derivatives reforms as part of efforts to deepen and stabilise domestic capital markets.

Canvas not supported.

Is it working?

Adoption has been strong among major dealers and infrastructure is functioning as intended, bringing South Africa broadly into line with global OTC‑derivative norms. Residual challenges include ensuring consistent compliance among smaller participants, fine‑tuning data quality and managing the liquidity and collateral‑management implications of higher margining standards. The reforms complement broader market‑infrastructure conduct standards, benchmark transition to ZARONIA and prudential‑regulation strengthening and support the stability and attractiveness of South Africa’s derivatives markets for local and international investors.

Actions

SARB and the PA have issued the relevant notices and guidance, rolled out the Umoja reporting platform, overseen the phase‑in of initial‑margin requirements, engaged with market participants on implementation issues and begun using reported data in their risk‑monitoring frameworks.

Are there plans?

Authorities plan ongoing compliance monitoring, refinement of reporting protocols, coordination with trade repositories and market infrastructures, and periodic reviews of margin calibration and market impact in light of evolving international standards and local market conditions.

Is it on the agenda?

OTC‑derivatives reform and associated reporting remain in SARB and PA prudential‑policy strategies and are referenced in Budget Review 2026 in the context of strengthening financial market infrastructure and prudential regulation.

Goals

To modernise and standardise margin reporting for non-centrally cleared OTC derivatives, supporting systemic risk oversight, transparency, risk monitoring and compliance with global standards.

Summary

Over-the-counter (OTC) derivatives are financial contracts such as interest rate swaps, currency forwards and credit default swaps that are negotiated privately between two parties, not traded on a public exchange. They are widely used by banks, insurers and large corporations to manage financial risk. Because they are not publicly traded, their risks can be difficult for regulators to see. South Africa has aligned its OTC derivatives rules with international standards, requiring collateral (margin) to be posted against potential losses and all trades to be reported to a central trade repository (Strate — South Africa's central securities depository). The Umoja platform is the regulatory reporting system used by SARB and the Prudential Authority. Joint Regulatory Notice 2 of 2024, which mandated margin reporting on qualifying OTC derivative trades through the Umoja platform, was implemented. Initial margin phase-in requirements were completed by September 2025. Key market participants are meeting the new margin and reporting standards. Strate is coordinating the reporting infrastructure.

Canvas not supported.

Is it working?

Most industry participants are compliant with the Umoja margin reporting requirements. Technical improvements are continuing. The transition from JIBAR to ZARONIA adds a related dimension, as legacy OTC contracts referencing the old JIBAR rate must also transition to the new ZARONIA rate by 31 December 2026.

Actions

Rollout is proceeding as planned and key market participants are complying with new margin and reporting standards. Some industry feedback has been used to refine operational protocols.

Are there plans?

Biannual compliance audits, published reporting protocols and ongoing coordination with Strate and industry are planned.

Is it on the agenda?

Yes. OTC derivatives regulation is a standing item in SARB and PA strategy, included in quarterly market risk committee meetings.

Goals

To ensure that complex financial contracts traded privately between institutions (known as over-the-counter or OTC derivatives) meet international standards for collateral, risk management and regulatory reporting. This is intended to reduce the risk that hidden exposures could destabilise the financial system.

Summary

Over-the-counter (OTC) derivatives are financial contracts such as interest rate swaps, currency forwards and credit default swaps that are negotiated privately between two parties, not traded on a public exchange. They are widely used by banks, insurers and large corporations to manage financial risk. Because they are not publicly traded, their risks can be difficult for regulators to see. South Africa has aligned its OTC derivatives rules with international standards, requiring collateral (margin) to be posted against potential losses and all trades to be reported to a central trade repository (Strate — South Africa's central securities depository). The Umoja platform is the regulatory reporting system used by SARB and the Prudential Authority. Joint Regulatory Notice 2 of 2024, which mandated margin reporting on qualifying OTC derivative trades through the Umoja platform, was implemented. Initial margin phase-in requirements were completed by September 2025. Key market participants are meeting the new margin and reporting standards. Strate is coordinating the reporting infrastructure.

Canvas not supported.

Is it working?

Most industry participants are compliant with the Umoja margin reporting requirements. Technical improvements are continuing. The transition from JIBAR to ZARONIA adds a related dimension, as legacy OTC contracts referencing the old JIBAR rate must also transition to the new ZARONIA rate by 31 December 2026.

Actions

Rollout is proceeding as planned and key market participants are complying with new margin and reporting standards. Some industry feedback has been used to refine operational protocols.

Are there plans?

Biannual compliance audits, published reporting protocols and ongoing coordination with Strate and industry are planned.

Is it on the agenda?

Yes. OTC derivatives regulation is a standing item in SARB and PA strategy, included in quarterly market risk committee meetings.

Goals

To ensure that complex financial contracts traded privately between institutions (known as over-the-counter or OTC derivatives) meet international standards for collateral, risk management and regulatory reporting. This is intended to reduce the risk that hidden exposures could destabilise the financial system.

Analyst: Tinashe Kambadza
Status: In progress
Last Updated:
Next Update:
Reform Area:
Reform:

    If you would like to alert our analysts to an update you are aware of in this particular reform area, please complete the form below and submit it to us. Please ensure you include links to any press releases or other documents to confirm the reforms and provide detail to allow our analysts to assess the changes. Our team will review it.